BD Nexiva closed IV catheter system Single Port, packaged with MaxZero needle-free connector

Great on their own. Even better together. Provide seamless care, with an IV catheter that lasts. Preserving sites and protecting veins

Together the benefits are 1,2,*: Longer dwell time, Improved patient satisfaction, improved nursing efficiency and reduced costs10. The BD Nexiva closed IV catheter system, the first-of-its-kind all-in-one closed system IV catheter, is designed to minimize the risk of IV catheter failure. 1,10

Longer dwell times

Proprietary BD Vialon biomaterial enables longer dwell times,2‡ supporting the current Infusion Therapy Standards of Practise for clinically indicated site rotation.3

Integrated system

As an integrated system, the BD Nexiva system needs fewer add-on devices, minimizing the number of manipulations that may lead to touch contamination and accidental disconnections.3,4||


The catheter's built-in stabilisation platform* minimizes movement that can lead to catheter complications, restarts and associated costs, and reduces dislodgement by 84%.5† The system also meets INS standards and CDC guidelines for catheter stabilisation.1,3

BD Instaflash needle technology

BD Instaflash needle technology quick blood visualisation may help improve insertion success and therefore, reduce insertion attempts.

Reduced costs

In a 2014 clinical study, it was demonstrated that BD Nexiva catheters had a low rate of phlebitis and a median dwell time of 144 hours for those in place for 24 hours or more.6 The longer dwell times of closed systems led, in one study, to a cost reduction of approximately $1M per year per 1,000 beds compared to open systems.6

Minimized treatment delays and complications

The BD Nexiva system is power-injection compatible, minimizing the need to exchange catheter or tubing. Single and dual ports and 18- to 22-G catheters are indicated for use in computed tomography (CT) power injection. Furthermore, the integrated system prevents leaking at the catheter-extension set connection.

Reduces manipulations

Integrated extension tubing and stabilisation platform‡ reduce manipulations and movement at the site that may lead to dislodgement§ and phlebitis.2,6

Reduces accidental dislodgement

Clinically demonstrated to reduce accidental dislodgement2|| and complies with the Infusion Therapy Standards of Practice and CDC guidelines for catheter stabilisation.1,5

Lessens blood exposure

98% reduced blood exposure during insertion due to the BD Nexiva IV catheter preassembled systems.2§

Lowers chance of mechanical phlebitis

Proprietary BD Vialon™ biomaterial softens up to 70% in the vein, enabling longer dwell times and reducing the chance of mechanical phlebitis by up to 50%. 3**

BD Nexiva IV catheter dwells longer

In a randomised study comparing the BD Nexiva IV catheter to an open catheter system, the median dwell time for BD Nexiva IV catheters was six days or four days for the open system.6

BD Nexiva IV catheter preserves sites

By preserving sites for longer, the BD Nexiva IV catheter helps patients get the medication they need as scheduled, potentially decreasing their length of stay.2,6,7

Related Products

Advanced insertion techniques possible with BD Nexiva

An integrated approach to peripheral vascular access insertion utilizing no-touch technique.  Learn about the different advanced insertion techniques possible using BD Nexiva TM closed IV catheter system.

Nouvelles méthodes d’insertion possible avec BD Nexiva

Une approche intégrée à l'insertion d'accès vasculaire périphérique utilisant une technique sans contact. Découvrez les différentes techniques d’insertion avancées possibles avec le système clos de cathéter intraveineux BD Nexiva

BD MaxZero needle-free connector

Protect clinicians and patients across all your care settings with the clinically proven technology of the BD MaxPlus™ connector, now in a smaller size.

Learn more

Please note, not all products, services or features of products and services may be available in your local area. Please check with your local BD representative.


* When used with an IV site securement dressing

† Compared to 96 hours with an open system

‡ When used with an IV site securement dressing

|| Compared to the B. Braun Introcan Safety® catheter with the Bard Statlock® IV Ultra stabilisation device

§ Compared to an open system

** Compared with an FEP catheter

  1. Gonzalez Lopez J, Arribi Viela A, Fernandez Del Palacio E et al. Indwell times, complications and costs of open vs closed safety peripheral intravenous catheters: a randomized study. J Hosp Infect 2014;86(2):117-126.
  2. Williams A. Catheter occlusion in home infusion: Does needless connector (NC) design matter? INS 2016
  3. O'Grady NP, Alexander M, Burns LA, et al. Guidelines for the Prevention of Intravascular Catheter-Related Infections. Centers for Disease Control and Prevention; 2011:36.
  4. Infusion Nurses Society. Infusion Therapy Standards of Practice. J Infus Nurs. 2016;39(1S).
  5. Alexander M, Corrigan A, Gorski L, et al. Infusion nursing: an evidence based approach. 3rd ed. St. Louis, MO: Saunders Elsevier; 2010:410.
  6. Bausone-Gazda D, Lefaiver CA, Walters SA. A randomised controlled trial to compare the complications of 2 peripheral intravenous catheter-catheter-stabilisation systems. J Infus Nurs. 2010;33(6):371-384.
  7. Maki DG, Ringer M. Risk factors for infusion-related phlebitis with small peripheral venous catheters. Annals of Internal Medicine. 1991;114:845-854.
  8. González López JL, Arribi Vilela A, Fernández del Palacio E, Olivares Corral J, Benedicto Martí C, Herrera Portal P. Indwell times, complications and costs of open vs closed safety peripheral intravenous catheters: a randomised study. J Hosp Infect. 2014;86(2):117-126.
  9. Woodley WD, Ferriter MS, Sullivan VJ, Harvey AJ. Evaluation of PU and FEP peripheral IV catheters utilising a sensitive, accelerated in vivo thrombus-occlusion model. Association for Vascular Access. Twenty-sixth annual meeting for the Association for Vascular Access. 2012.
  10. Helm RE, Klausner JD, Klemperer JD, et al. Accepted but unacceptable: peripheral IV catheter failure. Infus Nurs Society. 2015;38(3):189-203.

This site uses cookies. If you click accept cookies then all cookies will be written. Please review our cookies policy and configure your cookies for your experience.